Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2020 09:54 ET | Source: Genmab A/S

Genmab to Present at the 38th Annual J.P. Morgan Healthcare Conference

Media Release Copenhagen, Denmark, January 6, 2020 Genmab A/S (Nasdaq: GMAB) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the 38th Annual J.P. Morgan...
January 02, 2020 16:25 ET | Source: Genmab A/S

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Company Announcement Copenhagen, Denmark; January 2, 2020 – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses...
January 02, 2020 09:29 ET | Source: Genmab A/S

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Company Announcement Copenhagen, Denmark; January 2, 2020 – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the...
December 20, 2019 10:19 ET | Source: Genmab A/S

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Company Announcement Copenhagen, Denmark; December 20, 2019 – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses...
December 19, 2019 10:19 ET | Source: Genmab A/S

Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics

Company Announcement Genmab and CureVac enter broad strategic partnership Companies to conduct joint research on first program; option for Genmab to initiate three additional programs during 5-year...
December 13, 2019 06:32 ET | Source: Genmab A/S

CHMP Issues Positive Opinion Recommending DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma

Company Announcement CHMP issued positive opinion for DARZALEX® in combination with bortezomib, thalidomide and dexamethasone for the treatment of adult patients with newly diagnosed multiple myeloma...
December 09, 2019 08:27 ET | Source: Genmab A/S

Genmab to Hold 2019 R&D Update and ASH Data Review Meeting

Media Release Event to be held today in Orlando, FloridaIndependent experts to discuss data presented at the 2019 ASH Annual MeetingMeeting to be webcast live and archived on www.genmab.com ...
December 05, 2019 17:36 ET | Source: Genmab A/S

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Company Announcement Copenhagen, Denmark; December 5, 2019 – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses...
December 05, 2019 17:32 ET | Source: Genmab A/S

Grant of Restricted Stock Units to Board Members, Management and Employees and Grant of Warrants to Employees in Genmab

Company Announcement Copenhagen, Denmark; December 5, 2019 – Genmab A/S (Nasdaq: GMAB) announced today that at a board meeting the board decided to grant 83,658 restricted stock units to members of...
December 05, 2019 03:49 ET | Source: Genmab A/S

Genmab Achieves USD 100 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen

Company Announcement Genmab to receive milestone payment of USD 100 Million in DARZALEX collaboration Milestone triggered by sales of DARZALEX reaching USD 2.5 billion in a calendar year Copenhagen,...